161 related articles for article (PubMed ID: 3141239)
1. Therapeutic regimens in acute experimental hemorrhagic pancreatitis. Effects of hydration, oxygenation, peritoneal lavage, and a potent protease inhibitor.
Niederau C; Crass RA; Silver G; Ferrell LD; Grendell JH
Gastroenterology; 1988 Dec; 95(6):1648-57. PubMed ID: 3141239
[TBL] [Abstract][Full Text] [Related]
2. Camostate (FOY-305) improves the therapeutic effect of peritoneal lavage on taurocholate induced pancreatitis.
Leonhardt U; Seidensticker F; Fussek M; Stöckmann F; Creutzfeldt W
Gut; 1990 Aug; 31(8):934-7. PubMed ID: 2387520
[TBL] [Abstract][Full Text] [Related]
3. Beneficial effects of cholecystokinin-receptor blockade and inhibition of proteolytic enzyme activity in experimental acute hemorrhagic pancreatitis in mice. Evidence for cholecystokinin as a major factor in the development of acute pancreatitis.
Niederau C; Liddle RA; Ferrell LD; Grendell JH
J Clin Invest; 1986 Oct; 78(4):1056-63. PubMed ID: 2428840
[TBL] [Abstract][Full Text] [Related]
4. [Gabexate mesilate in the treatment of acute pancreatitis. Results of a Hannover multicenter double-blind study with 50 patients].
Freise J; Melzer P; Schmidt FW; Horbach L
Z Gastroenterol; 1986 Apr; 24(4):200-11. PubMed ID: 3087076
[TBL] [Abstract][Full Text] [Related]
5. Effect of FOY-305 (camostate) on severe acute pancreatitis in two experimental animal models.
Lankisch PG; Pohl U; Göke B; Otto J; Wereszczynska-Siemiatkowska U; Gröne HJ; Rahlf G
Gastroenterology; 1989 Jan; 96(1):193-9. PubMed ID: 2909420
[TBL] [Abstract][Full Text] [Related]
6. [Therapy of acute pancreatitis with a synthetic protease and phospholipase A2 inhibitor gabexate mesilate].
Freise J
Fortschr Med; 1983 Aug; 101(31-32):1432-6. PubMed ID: 6194089
[TBL] [Abstract][Full Text] [Related]
7. Gabexate mesilate (FOY) protects against ceruletide-induced acute pancreatitis in the rat.
Wisner JR; Renner IG; Grendell JH; Niederau C; Ferrell LD
Pancreas; 1987; 2(2):181-6. PubMed ID: 2442741
[TBL] [Abstract][Full Text] [Related]
8. Controlled trial of protease inhibitor gabexelate mesilate (FOY) in the treatment of acute pancreatitis.
Yang CY; Chang-Chien CS; Liaw YF
Pancreas; 1987; 2(6):698-700. PubMed ID: 3125546
[TBL] [Abstract][Full Text] [Related]
9. Effect of camostate administration for two weeks on experimental pancreatitis in mice and rats.
Leonhardt U; Seidensticker F; Stöckmann F; Creutzfeldt W
Pancreas; 1993 Jan; 8(1):98-102. PubMed ID: 7678329
[TBL] [Abstract][Full Text] [Related]
10. Regional effects of nafamostat, a novel potent protease and complement inhibitor, on severe necrotizing pancreatitis.
Keck T; Balcom JH; Antoniu BA; Lewandrowski K; Warshaw AL; Fernández-del Castillo CF
Surgery; 2001 Aug; 130(2):175-81. PubMed ID: 11490346
[TBL] [Abstract][Full Text] [Related]
11. [The protease inhibitor gabexate mesilate in experimentally-induced acute pancreatitis with early gram-negative infection in the Göttingen minipig: therapeutic efficacy and effects on blood coagulation and fibrinolysis].
Heitz J; Semsch B; Emde C; Jansen U; Schäfer JH
Z Gastroenterol; 1990 Apr; 28(4):192-7. PubMed ID: 2119091
[TBL] [Abstract][Full Text] [Related]
12. Gabexate mesilate and camostate: new inhibitors of phospholipase A2 and their influence on the alpha-amylase activity in serum of patients with acute pancreatitis.
Freise J; Schmidt FW; Magerstedt P; Schmid K
Clin Biochem; 1985 Aug; 18(4):224-9. PubMed ID: 2412725
[TBL] [Abstract][Full Text] [Related]
13. Synthetic antiproteases in acute pancreatitis: an experimental study.
Dobosz M; Sledziński Z; Babicki A; Juszkiewicz P; Basiński A; Wajda Z
Mt Sinai J Med; 1992 Jan; 59(1):43-6. PubMed ID: 1734237
[TBL] [Abstract][Full Text] [Related]
14. Prevention of the spread of experimental acute pancreatitis by intraductal administration of a synthetic protease inhibitor in dogs.
Wakayama T; Itoh T; Shibayama K; Idezuki Y
Am J Gastroenterol; 1989 Mar; 84(3):272-8. PubMed ID: 2465686
[TBL] [Abstract][Full Text] [Related]
15. A novel thermosensitive in-situ gel of gabexate mesilate for treatment of traumatic pancreatitis: An experimental study.
Gao HJ; Song Q; Lv FQ; Wang S; Wang YR; Luo YK; Mei XG; Tang J
J Huazhong Univ Sci Technolog Med Sci; 2015 Oct; 35(5):707-711. PubMed ID: 26489626
[TBL] [Abstract][Full Text] [Related]
16. Peritoneal lavage with aprotinin in patients with severe acute pancreatitis. Effects on plasma and peritoneal levels of trypsin and leukocyte proteases and their major inhibitors.
Berling R; Borgström A; Ohlsson K
Int J Pancreatol; 1998 Aug; 24(1):9-17. PubMed ID: 9746884
[TBL] [Abstract][Full Text] [Related]
17. Effect on hemodynamics of therapeutic infusion of gabexate mesilate (FOY) in experimental acute pancreatitis.
Dobosz M; Sledziński Z; Basiński A; Stanek A; Babicki A; Wajda Z
Res Exp Med (Berl); 1989; 189(2):77-84. PubMed ID: 2499022
[TBL] [Abstract][Full Text] [Related]
18. Toxic products in hemorrhagic ascitic fluid generated during experimental acute hemorrhagic pancreatitis in dogs and a treatment which reduces their effect.
Satake K; Koh I; Nishiwaki H; Umeyama K
Digestion; 1985; 32(2):99-105. PubMed ID: 4043568
[TBL] [Abstract][Full Text] [Related]
19. Synthetic versus natural protease inhibitors in acute experimental pancreatitis.
Lankisch PG; Pohl U; Otto J
Dig Dis Sci; 1988 Nov; 33(11):1497-8. PubMed ID: 3180989
[No Abstract] [Full Text] [Related]
20. Pharmacological studies of FUT-175, nafamostat mesilate. V. Effects on the pancreatic enzymes and experimental acute pancreatitis in rats.
Iwaki M; Ino Y; Motoyoshi A; Ozeki M; Sato T; Kurumi M; Aoyama T
Jpn J Pharmacol; 1986 Jun; 41(2):155-62. PubMed ID: 2427760
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
